Literature DB >> 16100562

Role of vascular endothelial growth factor in ovarian physiology - an overview.

Monika M Kaczmarek1, Dieter Schams, Adam J Ziecik.   

Abstract

In the female reproductive system, as in a few adult tissues, angiogenesis occurs as a normal process and is essential for normal tissue growth and development. In the ovary, new blood vessel formation facilitates oxygen, nutrients, and hormone substrate delivery, and also secures transfer of different hormones to targeted cells. Ovarian follicle and the corpus luteum (CL) have been shown to produce several angiogenic factors, however, vascular endothelial growth factor (VEGF) is thought to play a paramount role in the regulation of normal and abnormal angiogenesis in the ovary. Expression of VEGF in ovarian follicles depends on follicular size. Inhibition of VEGF expression results in decreased follicle angiogenesis and the lack of the development of mature antral follicles. The permeabilizing activity of VEGF is thought to be involved in follicle antrum formation and in the ovulatory process. In the CL, VEGF expression corresponds to different patterns of angiogenesis during its lifespan. In most the species, higher VEGF expression in the early luteal phase is essential for the development of a high-density capillary network in the CL. However, high VEGF expression may be still maintained in the mid-luteal phase to increase vascular permeability that results in enhancement of luteal function. During gestation, VEGF is thought to be important for the persistence of the CL function for a longer than in the nonfertile cycle period of time. Further elucidation of specific roles of VEGF in ovarian physiology may help to understand the phenomenon of luteal insufficiency and reveal novel strategies of ovarian angiogenesis manipulation to alleviate infertility or to control fertility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100562

Source DB:  PubMed          Journal:  Reprod Biol        ISSN: 1642-431X            Impact factor:   2.376


  24 in total

1.  Bone morphogenetic protein 7 increased vascular endothelial growth factor (VEGF)-a expression in human granulosa cells and VEGF receptor expression in endothelial cells.

Authors:  Ikumi Akiyama; Osamu Yoshino; Yutaka Osuga; Jia Shi; Miyuki Harada; Kaori Koga; Yasushi Hirota; Tetsuya Hirata; Tomoyuki Fujii; Shigeru Saito; Shiro Kozuma
Journal:  Reprod Sci       Date:  2013-09-10       Impact factor: 3.060

Review 2.  Angiogenesis in the human corpus luteum.

Authors:  Norihiro Sugino; Aki Matsuoka; Ken Taniguchi; Hiroshi Tamura
Journal:  Reprod Med Biol       Date:  2008-04-17

3.  bFGF and VEGF improve the quality of vitrified-thawed human ovarian tissues after xenotransplantation to SCID mice.

Authors:  Bei-Jia Kang; Yan Wang; Long Zhang; Zhun Xiao; Shang-Wei Li
Journal:  J Assist Reprod Genet       Date:  2015-12-28       Impact factor: 3.412

4.  Regulation of granulosa and theca cell transcriptomes during ovarian antral follicle development.

Authors:  Michael K Skinner; Michelle Schmidt; Marina I Savenkova; Ingrid Sadler-Riggleman; Eric E Nilsson
Journal:  Mol Reprod Dev       Date:  2008-09       Impact factor: 2.609

5.  Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a trkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway.

Authors:  Marcela Julio-Pieper; Patricia Lozada; Veronica Tapia; Margarita Vega; Cristián Miranda; David Vantman; Sergio R Ojeda; Carmen Romero
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

Review 6.  Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.

Authors:  Shinichi Sakamoto; A Jacqueline Ryan; Natasha Kyprianou
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

7.  Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro.

Authors:  Divya K Shah; K M J Menon; Lourdes M Cabrera; Anjel Vahratian; Shahryar K Kavoussi; Dan I Lebovic
Journal:  Fertil Steril       Date:  2009-04-01       Impact factor: 7.329

8.  VEGF and bFGF increase survival of xenografted human ovarian tissue in an experimental rabbit model.

Authors:  Lin Wang; Ying-fen Ying; Yin-luan Ouyang; Jing-fen Wang; Jian Xu
Journal:  J Assist Reprod Genet       Date:  2013-09-06       Impact factor: 3.412

9.  Anti-VEGFA Therapy Reduces Tumor Growth and Extends Survival in a Murine Model of Ovarian Granulosa Cell Tumor.

Authors:  Mayra Tsoi; Marie-Noëlle Laguë; Alexandre Boyer; Marilène Paquet; Marie-Ève Nadeau; Derek Boerboom
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

10.  Blood vessel remodeling in pig ovarian follicles during the periovulatory period: an immunohistochemistry and SEM-corrosion casting study.

Authors:  Alessandra Martelli; Maria Grazia Palmerini; Valentina Russo; Carlo Rinaldi; Nicola Bernabò; Oriana Di Giacinto; Paolo Berardinelli; Stefania Annarita Nottola; Guido Macchiarelli; Barbara Barboni
Journal:  Reprod Biol Endocrinol       Date:  2009-07-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.